| Bioactivity | Bromoacetamido-PEG4-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Bromoacetamido-PEG4-acid is also a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2]. | ||||||||||||
| Invitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[2]. | ||||||||||||
| Name | Bromoacetamido-PEG4-acid | ||||||||||||
| CAS | 1807518-67-7 | ||||||||||||
| Formula | C13H24BrNO7 | ||||||||||||
| Molar Mass | 386.24 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Bromoacetamido-PEG4-acid
CAS: 1807518-67-7 F: C13H24BrNO7 W: 386.24
Bromoacetamido-PEG4-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. Bromoacetamido-PEG4-
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.